<!DOCTYPE html>
<html lang="zh-CN">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <meta name="description" content="chapt 11.9 æ°´æ¨é…¸  ä¸€ã€ é‡ç‚¹åè¯è§£é‡Š æ°´æ¨é…¸ (Salicylic Acid, SA): ä¸€ç§é…šç±»æ¤ç‰©æ¿€ç´ ï¼Œç»“æ„ç®€å•ï¼ˆé‚»ç¾ŸåŸºè‹¯ç”²é…¸ï¼‰ã€‚å®ƒåœ¨æ¤ç‰©æŠµå¾¡æ´»ä½“è¥å…»å‹ç—…åŸèŒ (Biotrophs)ï¼ˆå¦‚ç—…æ¯’ã€ç™½ç²‰èŒï¼‰å’Œåˆºå¸å¼æ˜†è™«çš„å…ç–«ååº”ä¸­èµ·æ ¸å¿ƒä½œç”¨ï¼Œè¯±å¯¼ç³»ç»Ÿè·å¾—æ€§æŠ—æ€§ (SAR) å’Œ PR åŸºå› ...">
    <meta name="keywords" content="æ¤ç‰©ç”Ÿç†å­¦/ååŠ, chapt 11.9 æ°´æ¨é…¸">
    <meta name="author" content="Yukari502">
    <meta name="article-slug" content="chapt-119-æ°´æ¨é…¸">
    <meta name="root-path" content="../../">

    <!-- Open Graph / Facebook -->
    <meta property="og:type" content="article">
    <meta property="og:url" content="https://yukari502.github.io/posts/æ¤ç‰©ç”Ÿç†å­¦ååŠ/chapt-119-æ°´æ¨é…¸.html">
    <meta property="og:title" content="chapt 11.9 æ°´æ¨é…¸">
    <meta property="og:description" content="chapt 11.9 æ°´æ¨é…¸  ä¸€ã€ é‡ç‚¹åè¯è§£é‡Š æ°´æ¨é…¸ (Salicylic Acid, SA): ä¸€ç§é…šç±»æ¤ç‰©æ¿€ç´ ï¼Œç»“æ„ç®€å•ï¼ˆé‚»ç¾ŸåŸºè‹¯ç”²é…¸ï¼‰ã€‚å®ƒåœ¨æ¤ç‰©æŠµå¾¡æ´»ä½“è¥å…»å‹ç—…åŸèŒ (Biotrophs)ï¼ˆå¦‚ç—…æ¯’ã€ç™½ç²‰èŒï¼‰å’Œåˆºå¸å¼æ˜†è™«çš„å…ç–«ååº”ä¸­èµ·æ ¸å¿ƒä½œç”¨ï¼Œè¯±å¯¼ç³»ç»Ÿè·å¾—æ€§æŠ—æ€§ (SAR) å’Œ PR åŸºå› ...">
    <meta property="og:site_name" content="Digital Garden">

    <!-- Twitter -->
    <meta property="twitter:card" content="summary_large_image">
    <meta property="twitter:url" content="https://yukari502.github.io/posts/æ¤ç‰©ç”Ÿç†å­¦ååŠ/chapt-119-æ°´æ¨é…¸.html">
    <meta property="twitter:title" content="chapt 11.9 æ°´æ¨é…¸">
    <meta property="twitter:description" content="chapt 11.9 æ°´æ¨é…¸  ä¸€ã€ é‡ç‚¹åè¯è§£é‡Š æ°´æ¨é…¸ (Salicylic Acid, SA): ä¸€ç§é…šç±»æ¤ç‰©æ¿€ç´ ï¼Œç»“æ„ç®€å•ï¼ˆé‚»ç¾ŸåŸºè‹¯ç”²é…¸ï¼‰ã€‚å®ƒåœ¨æ¤ç‰©æŠµå¾¡æ´»ä½“è¥å…»å‹ç—…åŸèŒ (Biotrophs)ï¼ˆå¦‚ç—…æ¯’ã€ç™½ç²‰èŒï¼‰å’Œåˆºå¸å¼æ˜†è™«çš„å…ç–«ååº”ä¸­èµ·æ ¸å¿ƒä½œç”¨ï¼Œè¯±å¯¼ç³»ç»Ÿè·å¾—æ€§æŠ—æ€§ (SAR) å’Œ PR åŸºå› ...">

    <title>chapt 11.9 æ°´æ¨é…¸ - D.RAY</title>

    <!-- Google Fonts -->
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    <link
        href="https://fonts.googleapis.com/css2?family=Outfit:wght@300;400;500;600;700&family=JetBrains+Mono:wght@400;500&display=swap"
        rel="stylesheet">

    <!-- Highlight.js -->
    <link rel="stylesheet"
        href="https://cdnjs.cloudflare.com/ajax/libs/highlight.js/11.9.0/styles/atom-one-dark.min.css">
    <script src="https://cdnjs.cloudflare.com/ajax/libs/highlight.js/11.9.0/highlight.min.js"></script>

    <!-- KaTeX -->
    <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/katex@0.16.9/dist/katex.min.css">
    <script defer src="https://cdn.jsdelivr.net/npm/katex@0.16.9/dist/katex.min.js"></script>
    <script defer src="https://cdn.jsdelivr.net/npm/katex@0.16.9/dist/contrib/auto-render.min.js"></script>

    <!-- Marked.js for Markdown parsing -->
    <script src="https://cdn.jsdelivr.net/npm/marked/marked.min.js"></script>

    <!-- Mermaid.js for diagrams and flowcharts -->
    <script type="module">
        import mermaid from 'https://cdn.jsdelivr.net/npm/mermaid@10/dist/mermaid.esm.min.mjs';
        mermaid.initialize({
            startOnLoad: false,
            theme: 'dark',
            themeVariables: {
                primaryColor: '#8b5cf6',
                primaryTextColor: '#fff',
                primaryBorderColor: '#7c3aed',
                lineColor: '#a78bfa',
                secondaryColor: '#6d28d9',
                tertiaryColor: '#5b21b6'
            }
        });
        window.mermaid = mermaid;
    </script>

    <!-- Custom Styles -->
    <link rel="stylesheet" href="../../style.css">
    <link rel="icon" href="../../ico/favicon.ico" type="image/x-icon">

    <style>
        .article-page {
            max-width: 1150px;
            margin: 0 auto;
            padding: 2rem;
        }

        .article-header {
            margin-bottom: 3rem;
            padding-bottom: 2rem;
            border-bottom: 2px solid var(--border-color);
        }

        .article-title {
            font-size: 2.5rem;
            font-weight: 700;
            margin-bottom: 1rem;
            line-height: 1.2;
        }

        .article-meta {
            display: flex;
            gap: 1rem;
            color: var(--text-secondary);
            font-size: 0.95rem;
        }

        .article-meta span {
            display: flex;
            align-items: center;
            gap: 0.3rem;
        }

        .back-link {
            display: inline-flex;
            align-items: center;
            gap: 0.5rem;
            color: var(--accent-color);
            text-decoration: none;
            margin-bottom: 2rem;
            font-weight: 500;
            transition: transform 0.2s;
        }

        .back-link:hover {
            transform: translateX(-4px);
        }

        .article-content {
            font-size: 1.1rem;
            line-height: 1.8;
        }

        @media (max-width: 768px) {
            .article-page {
                padding: 1rem;
            }

            .article-title {
                font-size: 2rem;
            }
        }

        .article-footer {
            margin-top: 4rem;
            padding-top: 2rem;
            border-top: 1px solid var(--border-color);
            text-align: center;
            color: var(--text-secondary);
            font-size: 0.85rem;
        }

        .article-footer .disclaimer {
            font-size: 0.75rem;
            margin-top: 0.5rem;
            font-style: italic;
            opacity: 0.8;
        }
    </style>
    <meta name="build-hash" content="789ebebe2576acaf279b38633f956dcb">
</head>

<body>
    <div class="article-page">
        <a href="../../" class="back-link">
            <svg xmlns="http://www.w3.org/2000/svg" width="20" height="20" viewBox="0 0 24 24" fill="none"
                stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round">
                <line x1="19" y1="12" x2="5" y2="12"></line>
                <polyline points="12 19 5 12 12 5"></polyline>
            </svg>
            è¿”å›ä¸»é¡µ
        </a>

        <div class="article-header">
            <h1 class="article-title">chapt 11.9 æ°´æ¨é…¸</h1>
            <div class="article-meta">
                <span>ğŸ“… 2026-01-14</span>
                <span>ğŸ“‚ æ¤ç‰©ç”Ÿç†å­¦/ååŠ</span>
            </div>
        </div>

        <article class="article-content markdown-body" id="article-content">
            <!-- Content will be rendered here -->
        </article>

        <!-- Store markdown content in a script tag -->
        <script type="text/markdown" id="markdown-source">
# chapt 11.9 æ°´æ¨é…¸

### ä¸€ã€ é‡ç‚¹åè¯è§£é‡Š

**æ°´æ¨é…¸ (Salicylic Acid, SA):** ä¸€ç§é…šç±»æ¤ç‰©æ¿€ç´ ï¼Œç»“æ„ç®€å•ï¼ˆé‚»ç¾ŸåŸºè‹¯ç”²é…¸ï¼‰ã€‚å®ƒåœ¨æ¤ç‰©æŠµå¾¡**æ´»ä½“è¥å…»å‹ç—…åŸèŒ (Biotrophs)**ï¼ˆå¦‚ç—…æ¯’ã€ç™½ç²‰èŒï¼‰å’Œåˆºå¸å¼æ˜†è™«çš„å…ç–«ååº”ä¸­èµ·æ ¸å¿ƒä½œç”¨ï¼Œè¯±å¯¼**ç³»ç»Ÿè·å¾—æ€§æŠ—æ€§ (SAR)** å’Œ *PR* åŸºå› è¡¨è¾¾ã€‚æ­¤å¤–ï¼Œå®ƒè¿˜æ¶‰åŠæ¤ç‰©äº§çƒ­ï¼ˆå¦‚å¤©å—æ˜Ÿç§‘æ¤ç‰©ï¼‰ã€å¼€èŠ±åŠè¡°è€è°ƒæ§,ã€‚

---

### äºŒã€ æ¤ç‰©ç”Ÿç†å­¦é‡ç‚¹å†…å®¹å½’çº³

**2. ç”Ÿç‰©åˆæˆ (Biosynthesis)**
*   **åŒé€”å¾„è®ºï¼š**
    1.  **ICS é€”å¾„ (ä¸»è¦)ï¼š** å‘ç”Ÿåœ¨**å¶ç»¿ä½“**ã€‚åˆ†æ”¯é…¸ $\rightarrow$ å¼‚åˆ†æ”¯é…¸ (ICS1) $\rightarrow$ IC-9-Glu (PBS3) $\rightarrow$ SAã€‚æ‹Ÿå—èŠ¥ä¸­å  95% è´¡çŒ®,ã€‚
    2.  **PAL é€”å¾„ï¼š** è‹¯ä¸™æ°¨é…¸ $\rightarrow$ è‚‰æ¡‚é…¸ $\rightarrow$ è‹¯ç”²é…¸ $\rightarrow$ SAã€‚
    3. Most SA is synthesized in the chloroplast,
conjugated in the cytoplasm and sequestered in
the vacuole

**3. ä»£è°¢ä¸ä¿®é¥°**
*   **ä¿®é¥°ï¼š** SA å¯è¢«ç³–åŸºåŒ–ï¼ˆç”Ÿæˆ SAG, SGEï¼‰å‚¨å­˜åœ¨æ¶²æ³¡ä¸­ï¼Œæˆ–è¢«ç”²åŸºåŒ–ç”ŸæˆæŒ¥å‘æ€§çš„ **æ°´æ¨é…¸ç”²é…¯ (MeSA)**ã€‚MeSA æ˜¯ä¸€ç§è„‚æº¶æ€§ä¿¡å·åˆ†å­ï¼Œå¯ç©¿è¿‡ç»†èƒè†œï¼Œæ˜¯é•¿è·ç¦»ä¿¡å·ä¼ é€’çš„è½½ä½“,ã€‚

**4. ä¿¡å·è½¬å¯¼æœºåˆ¶**
*   **è½¬å¯¼è¿‡ç¨‹ï¼š**
    1.  **æ°§åŒ–è¿˜åŸå¼€å…³ï¼š** SA ç§¯ç´¯ $\rightarrow$ ç»†èƒè¿˜åŸç¯å¢ƒ $\rightarrow$ NPR1 å¯¡èšä½“ï¼ˆäºŒç¡«é”®è¿æ¥ï¼‰è¿˜åŸä¸º **å•ä½“**ã€‚
    2.  **æ ¸å®šä½ï¼š** å•ä½“ NPR1 è¿›å…¥ç»†èƒæ ¸ã€‚
    3.  **è½¬å½•æ¿€æ´»ï¼š** NPR1 ä¸ **TGA** ç±»è½¬å½•å› å­ï¼ˆbZIPå®¶æ—ï¼‰äº’ä½œï¼Œå¢å¼º TGA å¯¹ *PR* åŸºå› å¯åŠ¨å­çš„ç»“åˆèƒ½åŠ›ï¼Œæ¿€æ´»è½¬å½•ã€‚
    4.  **WRKYs:** è®¸å¤š WRKY è½¬å½•å› å­ä½äºä¸‹æ¸¸ï¼Œå½¢æˆå¤æ‚çš„è°ƒæ§ç½‘ç»œï¼ˆå¦‚ WRKY70 æ˜¯ SA/JA äº¤äº’çš„èŠ‚ç‚¹ï¼‰ã€‚

---

### ä¸‰ã€ é‡ç‚¹å®éªŒä¸çªå˜ä½“æ¦‚è¿°

**2. *sid2* / *eds16* çªå˜ä½“åˆ†æ**
*   **èƒŒæ™¯ï¼š** ç­›é€‰ SA åˆæˆç¼ºé™·çªå˜ä½“ã€‚
*   **ç»“æœï¼š** *sid2* çªå˜ä½“ä¸­ SA å«é‡ä»…ä¸ºé‡ç”Ÿå‹çš„ 5-10%ï¼Œä¸” *PR-1* è¡¨è¾¾å—é˜»ï¼ŒæŠ—ç—…æ€§ä¸§å¤±ã€‚
*   **ç»“è®ºï¼š** è¯æ˜äº† **ICS1** æ˜¯æ‹Ÿå—èŠ¥ä¸­ç—…åŸè¯±å¯¼ SA åˆæˆçš„ä¸»æ•ˆé…¶ã€‚


### å››ã€ é—®é¢˜å›ç­” (Q&A)

**Q1: How do plants distinguish between biotrophic and necrotrophic pathogens? (æ¤ç‰©å¦‚ä½•åŒºåˆ†æ´»ä½“å’Œæ­»ä½“è¥å…»å‹ç—…åŸèŒï¼Ÿ)**
**A:** ä¸»è¦é€šè¿‡æ¿€æ´»ä¸åŒçš„æ¿€ç´ ä¿¡å·é€šè·¯ã€‚
*   **æ´»ä½“è¥å…»å‹ (Biotrophs):** è§¦å‘ **SA (æ°´æ¨é…¸)** é€”å¾„ï¼Œè¯±å¯¼ç»†èƒæ­»äº¡ï¼ˆHRï¼‰æ¥é™åˆ¶ç—…åŸæ‰©æ•£ï¼ˆå› ä¸ºæ´»ä½“èŒéœ€è¦æ´»ç»†èƒï¼‰ã€‚
*   **æ­»ä½“è¥å…»å‹ (Necrotrophs):** è§¦å‘ **JA (èŒ‰è‰é…¸)** é€”å¾„ï¼Œå› ä¸º HR å¯¼è‡´çš„ç»†èƒæ­»äº¡åè€Œæœ‰åˆ©äºæ­»ä½“èŒæ‘„å–è¥å…»ã€‚è¿™ä¸¤æ¡é€šè·¯é€šå¸¸ç›¸äº’æ‹®æŠ—ã€‚

**Q2: What is the relationship between SA levels and NPR1 stability? (SA æ°´å¹³ä¸ NPR1 ç¨³å®šæ€§æœ‰ä»€ä¹ˆå…³ç³»ï¼Ÿ)**
**A:** æ ¹æ® Fu et al. (2012) çš„å—ä½“æ¨¡å‹ï¼š
*   **æä½ SA:** NPR4 (é«˜äº²å’ŒåŠ›å—ä½“) ç»“åˆå¹¶é™è§£ NPR1 $\rightarrow$ æŠ‘åˆ¶åŸºç¡€é˜²å¾¡ï¼Œé˜²æ­¢èƒ½é‡æµªè´¹ã€‚
*   **ä¸­ç­‰ SA (PTI/SAR):** SA ç»“åˆ NPR4 ä½¿å…¶å¤±æ´»ï¼ŒNPR1 åœæ­¢é™è§£å¹¶ç§¯ç´¯ $\rightarrow$ æ¿€æ´»é˜²å¾¡åŸºå› ã€‚
*   **æé«˜ SA (ETI/HR):** SA ç»“åˆ NPR3 (ä½äº²å’ŒåŠ›å—ä½“)ï¼Œä»‹å¯¼ NPR1 é™è§£ $\rightarrow$ å¯èƒ½æœ‰åŠ©äºå¯åŠ¨ç»†èƒç¨‹åºæ€§æ­»äº¡ (Cell death)ï¼Œç‰ºç‰²å±€éƒ¨ç»†èƒä»¥éåˆ¶ç—…åŸã€‚

**Q3: Why is the discovery of the "PAL/BSH pathway" (2025) significant? (ä¸ºä»€ä¹ˆ 2025 å¹´å‘ç°çš„ PAL/BSH é€”å¾„å¾ˆé‡è¦ï¼Ÿ)**
**A:** é•¿æœŸä»¥æ¥ï¼Œæ•™ç§‘ä¹¦ï¼ˆåŸºäºæ‹Ÿå—èŠ¥ç ”ç©¶ï¼‰è®¤ä¸º ICS é€”å¾„æ˜¯ SA åˆæˆçš„ä¸»é€”å¾„ã€‚å¼ è·ƒæ—å›¢é˜Ÿçš„è¿™ä¸€å‘ç°è¯æ˜äº†åœ¨æ¼”åŒ–ä¸Šæ›´å¹¿æ³›çš„ç§å­æ¤ç‰©ï¼ˆå¦‚æ°´ç¨»ã€å¤§è±†ã€æ ‘æœ¨ï¼‰ä¸­ï¼Œ**PAL é€”å¾„** æ‰æ˜¯ä¸»å¯¼ã€‚è¯¥é€”å¾„æ¶‰åŠä»è‹¯ä¸™æ°¨é…¸ $\rightarrow$ è‹¯ç”²é…°è¾…é…¶A $\rightarrow$ æ°´æ¨é…¸è‹„é…¯ $\rightarrow$ SA çš„ä¸€ç³»åˆ—æ­¥éª¤ï¼Œä¿®æ­£äº†æˆ‘ä»¬å¯¹æ¤ç‰©æ¿€ç´ åˆæˆå¤šæ ·æ€§çš„è®¤çŸ¥ã€‚

        </script>

        <footer class="article-footer">
            <p>&copy; 2025 Yukari502. All rights reserved.</p>
            <p class="disclaimer">Disclaimer: Portions of this content may be generated by AI. Please exercise
                discretion and verify information independently.</p>
        </footer>
    </div>

    <script src="../../script.js"></script>
</body>

</html>